Surgical Decompression for Space-Occupying Hemispheric Infarction

Abstract

IMPORTANCEIn patients with space-occupying hemispheric infarction, surgical decompression reduces the risk of death and increases the chance of a favorable outcome. Uncertainties, however, still remain about the benefit of this treatment for specific patient groups.OBJECTIVE To assess whether surgical decompression for space-occupying hemispheric infarction is associated with a reduced risk of death and an increased chance of favorable outcomes, as well as whether this association is modified by patient characteristics.DATA SOURCES MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, and the Stroke Trials Registry were searched from database inception to October 9, 2019, for English-language articles that reported on the results of randomized clinical trials of surgical decompression vs conservative treatment in patients with space-occupying hemispheric infarction.STUDY SELECTION Published and unpublished randomized clinical trials comparing surgical decompression with medical treatment alone were selected.DATA EXTRACTION AND SYNTHESIS Patient-level data were extracted from the trial databases according to a predefined protocol and statistical analysis plan. The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline and the Cochrane Collaboration's tool for assessing risk of bias were used. One-stage, mixed-effect logistic regression modeling was used for all analyses. MAIN OUTCOMES AND MEASURESThe primary outcome was a favorable outcome (modified Rankin Scale [mRS] score Յ3) at 1 year after stroke. Secondary outcomes included death, reasonable (mRS score Յ4) and excellent (mRS score Յ2) outcomes at 6 months and 1 year, and an ordinal shift analysis across all levels of the mRS. Variables for subgroup analyses were age, sex, presence of aphasia, stroke severity, time to randomization, and involved vascular territories.RESULTS Data from 488 patients from 7 trials from 6 countries were available for analysis. The risk of bias was considered low to moderate for 6 studies. Surgical decompression was associated with a decreased chance of death (adjusted odds ratio, 0.16; 95% CI, 0.10-0.24) and increased chance of a favorable outcome (adjusted odds ratio, 2.95; 95% CI, 1.55-5.60), without evidence of heterogeneity of treatment effect across any of the prespecified subgroups. Too few patients were treated later than 48 hours after stroke onset to allow reliable conclusions in this subgroup, and the reported proportions of elderly patients reaching a favorable outcome differed considerably among studies. CONCLUSIONS AND RELEVANCEThe results suggest that the benefit of surgical decompression for space-occupying hemispheric infarction is consistent across a wide range of patients. The benefit of surgery after day 2 and in elderly patients remains uncertain.

Syndrome of the trephined: clinical spectrum, risk factors, and impact of cranioplasty on neurologic recovery in a prospective cohort

“…Thus, there is growing evidence that the incidence of SoT might be underestimated because of a lack of detailed evaluation of subtle neurologic manifestations in the absence of a sinking skin flap. Since DC is increasingly utilized to treat refractory intracranial hypertension for various etiologies, including stroke [28] and traumatic brain injury (TBI) [20], there is an unmet demand for a better understanding of the post-craniectomy related complications.…”

Effect of COPD on the Hospital Outcomes and Mortality among Hemorrhagic Stroke Patients. Sex Differences in a Population-Based Study

“…In relation to men, decompressive craniectomy was lower among the former. Perhaps, partly because of this, the HMI was significantly higher in men with COPD in our study, since surgical decompression has been associated with a decreased chance of death and increased chance of a favorable outcome [ 30 ]. As far as women are concerned, the use of decompressive craniectomy or IHM were not significantly different in both groups.…”

Histopathological Examination of the Possibility of a Purrfect Neuro Inflammatory Storm Leading to Choroid Blindness and Death Following Traumatic Brain Injury in Red Kangaroo (Osphranter rufus)

“…The IL-1 receptor antagonist, Anakinra, is another potential drug intervention in this context, and has already demonstrated safety and tolerability in marsupial TBI trials (Zhang et al, 2014). Experimental studies have reported that Anakinra is beneficial in wallabies with a combined TBI and tibial fracture (Reinink et al, 2021). This injury combination results in exacerbated neuroinflammation compared to an isolated TBI (Wickwire et al, 2018), and may bear similarities to what would occur in a combined TBI and T. gondii setting.…”